Evidence map›Paper›PMID 30544850›Full record

ArticlePathogens (Basel, Switzerland)2018

Host-Driven Phosphorylation Appears to Regulate the Budding Activity of the Lassa Virus Matrix Protein.

Christopher M Ziegler, Philip Eisenhauer, Inessa Manuelyan, Marion E Weir, Emily A Bruce, Bryan A Ballif, Jason Botten

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Christopher M ZieglerDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, VT 05405, USA. cziegler@uvm.edu.
Philip EisenhauerDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, VT 05405, USA. philip.eisenhauer@med.uvm.edu.
Inessa ManuelyanDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, VT 05405, USA. Inessa.Manuelyan@uvm.edu.
Marion E WeirDepartment of Biology, University of Vermont, Burlington, VT 05405, USA. marion.weir@cellsignal.com.
Emily A BruceDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, VT 05405, USA. Emily.Bruce@med.uvm.edu.
Bryan A BallifDepartment of Biology, University of Vermont, Burlington, VT 05405, USA. bballif@uvm.edu.ORCID 0000-0001-7650-3817
Jason BottenDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, VT 05405, USA. jbotten@uvm.edu.
University of Vermont · US

Funding

Vermont INBRE Administrative Supplement 2024 AWD 118P20GM103449 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI CHRISTOPHER S FRANCKLYN · 2012 to 2026
$58.4M
VERMONT IMMUNOBIOLOIGY/ INFECTIOUS DISEASES CENTERP20RR021905 · NCRR · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2006 to 2011
$14.5M
Vermont Immunology/Infectious Diseases CenterP30GM118228 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2016 to 2021
$6.8M
Multidisciplinary Training in Lung BiologyT32HL076122 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI IRVIN, CHARLES G, POYNTER, MATTHEW E · 2004 to 2023
$6.1M
Vermont Immunology/Infectious Diseases Training GrantT32AI055402 · NIAID · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI GARY E WARD · 2005 to 2026
$2.7M
Therapeutic antibodies for treatment of hantavirus cardiopulmonary syndromeR41AI132047 · NIAID · CELDARA MEDICAL, LLC · PI BOTTEN, JASON W., FANGER, MICHAEL W · 2017 to 2018
$800k
Identification of Novel Arenavirus Protein-Host Cellular Protein InteractionsR21AI088059 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BOTTEN, JASON W. · 2010 to 2011
$416k
National Institutes of Health 3R41AI132047-01S1National Institutes of Health 8P20GM103449National Institutes of Health P20RR021905National Institutes of Health P30GM118228National Institutes of Health R21 AI088059National Institutes of Health T32 AI055402National Institutes of Health T32 HL076122NCRR NIH HHS P20 RR021905NHLBI NIH HHS T32 HL076122NIAID NIH HHS R21 AI088059NIAID NIH HHS R41 AI132047NIAID NIH HHS T32 AI055402NIGMS NIH HHS P20 GM103449NIGMS NIH HHS P30 GM118228
6 · The paper itself

Abstract

Lassa mammarenavirus (LASV) is an enveloped RNA virus that can cause Lassa fever, an acute hemorrhagic fever syndrome associated with significant morbidity and high rates of fatality in endemic regions of western Africa. The arenavirus matrix protein Z has several functions during the virus life cycle, including coordinating viral assembly, driving the release of new virus particles, regulating viral polymerase activity, and antagonizing the host antiviral response. There is limited knowledge regarding how the various functions of Z are regulated. To investigate possible means of regulation, mass spectrometry was used to identify potential sites of phosphorylation in the LASV Z protein. This analysis revealed that two serines (S18, S98) and one tyrosine (Y97) are phosphorylated in the flexible N- and C-terminal regions of the protein. Notably, two of these sites, Y97 and S98, are located in (Y97) or directly adjacent to (S98) the PPXY late domain, an important motif for virus release. Studies with non-phosphorylatable and phosphomimetic Z proteins revealed that these sites are important regulators of the release of LASV particles and that host-driven, reversible phosphorylation may play an important role in the regulation of LASV Z protein function.

Indexed as

arenavirusbuddingLassa viruslate domainmass spectrometrymatrix proteinphosphorylationPPXYreleaseZ protein

Identifiers

PMID30544850
PMCPMC6313517
OpenAlexW2904056244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.